A5021357753- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Healthcare cost, quality, practices
- Cardiac electrophysiology and arrhythmias
University of Zagreb
2021-2024
Intra-cardiac echocardiography (ICE) has become an important tool for catheter ablation. Adoption of ICE imaging is still limited because its prohibitively high cost. Our aim was to study the safety and feasibility catheters reprocessing environmental financial impact.This a single center retrospective analysis all consecutive electrophysiology procedures in which were used from 2015 2022. In total, 1128 patients studied (70.6% male, mean age 57.9 ± 13.2 years). The majority related atrial...
Background: This study was conducted to evaluate compliance with guideline-directed optimal medical therapy (OMT) and its association early implantable cardioverter-defibrillator (ICD) activation in patients heart failure reduced ejection fraction (HFrEF). Methods: Retrospective data from 307 who underwent ICD implantation for primary prevention 2011 2017 were collected analyzed. Results: Among the participants, only 23.8% received maximum tolerated dose of OMT prior implantation, 59.0%...
Abstract Background Atrial fibrillation is the most common arrhythmia in general population and cryoballoon ablation gradually becoming a first-line treatment. However, data regarding long-term outcomes after this procedure are still lacking. Aim The goal was to show results of follow-up following pulmonary vein isolation patients with atrial (AF). Methods A total 126 were included study which 77.0% had paroxysmal (PAF). Successful treatment outcome defined as AF recurrence-free survival...
The goal: goal was to show results of a long-term follow-up following the cryoballoon pulmonary vein isolation in patients with atrial fibrillation (AF).
Abstract Introduction Implantable cardioverter-defibrillators (ICD) are gold-standard therapy for primary prevention (PP) of sudden cardiac death (SCD) in patients with heart failure reduced ejection fraction (HFrEF). According to relevant guidelines, ICDs should be implanted only after have been treated revascularization procedures and/or optimal medical (OMT) [1]. Due perceived high risk SCD and low chance improvement some receive “too early” the course disease [2]. Purpose To investigate...
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Implantable cardioverter defibrillator (ICD) is an effective therapy for primary (PP) and secondary prevention (SP) sudden cardiac death (SCD). ICD adverse events include inappropriate shocks (IS), device infection failure. Methods We analysed the data concerning all newly implanted ICDs in our institution from 2011 to 2017. Follow-up was collected until end 2019. Results In total, 507 were (85.4% male, 57.6 ± 14.0...
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Implantable cardioverter defibrillator (ICD) is gold standard therapy for primary and secondary prevention sudden cardiac death (SCD) ventricular tachyarrhythmias. While reducing arrhythmic mortality in patients with left dysfunction various causes, inherited arrhythmia syndromes after aborted SCD, these devices can have serious adverse effects including inappropriate shocks device-related infection. Purpose The...